Partner Christopher Swift was quoted in “Trump Takes Cue From Obama With North Korea Sanctions Tactic,” in TheStreet, about how President Trump’s recent executive order aligns with former administrations’ initiatives, including former President Obama’s Joint Comprehensive Plan of Action against Iran. Trump’s executive order expands the Treasury Department’s ability to cut off foreign financial institutions’ access to the U.S. financial system if they facilitate trade with North Korea.
“Notwithstanding Trump’s rhetoric, [his executive order] is consistent with the kind of policies we would have seen the Bush administration or Obama administration implement when faced with similar circumstances,” Swift said.
Swift also predicted that Trump’s executive order would not be an effective tool as similar sanctions have been against Iran. “It is something that was relatively effective in getting Iran to the negotiating table, but North Korea has different incentives. The North Koreans look at the world in a different way. They don’t have the same kind of domestic and political structure that the Iranians have.”
“Notwithstanding Trump’s rhetoric, [his executive order] is consistent with the kind of policies we would have seen the Bush administration or Obama administration implement when faced with similar circumstances,” Swift said.
Swift also predicted that Trump’s executive order would not be an effective tool as similar sanctions have been against Iran. “It is something that was relatively effective in getting Iran to the negotiating table, but North Korea has different incentives. The North Koreans look at the world in a different way. They don’t have the same kind of domestic and political structure that the Iranians have.”
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."